Researchers are calling for revisions to laws in the United States restricting physicians’ scope of practice and placing limits on innovation in healthcare delivery.
A $2.5 billion plan to fight the coronavirus outbreak was sent by the White House to Congress on Monday evening, as countries around the world raced to stem outbreaks of “untraceable” cases of the virus.
Hospital mergers and acquisitions may precipitate a modest decline in patient care quality; however, no differential changes in readmission or mortality rates were observed in acquired institutions compared with control hospitals,
Results from a narrative review published in the Journal of Medical Ethics suggest broad yet conditional support for data sharing among patients and the general public, with many studies citing concerns about confidentiality, privacy, data security, risk management, and accountability.
Medical school application costs may prevent students from lower-income backgrounds from entering the profession of medicine.
The relatively recent submissions by state policymakers requesting to close their Medicaid formularies highlighted ethical concerns regarding access and treatment of patients who are poor or vulnerable.
The growth of drug spending in the United States associated with government-protected market exclusivity is likely to continue.
Based on initial gains in health care access from the passage of the 2010 Patient Protection and ACA, the ACP offers recommendations on how to improve the law and achieve universal health care coverage.
FDA Commissioner, Scott Gottlieb MD, said, “The FDA shares the goal of ensuring that American patients have access to quality and affordable care that meets their needs.”
April 28, 2018 is National Prescription Drug Take Back Day.
